NASDAQ · ATEC
Healthcare · Medical - Devices
$10.54
Down-$0.18 (-1.68%)
Updated Oct 7, 2026, 1:24 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · ATEC
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
ATEC closed at $10.54 after 21 trading sessions, up 14.69% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $10.77 | $10.89 | $10.49 | $10.54 | 1.91M |
| Oct 5, 2026 | $9.98 | $10.75 | $9.94 | $10.72 | 2.06M |
| Oct 2, 2026 | $10.10 | $10.175 | $9.80 | $10.03 | 2.19M |
| Oct 1, 2026 | $10.265 | $10.45 | $9.81 | $9.90 | 2.29M |
| Sep 30, 2026 | $10.41 | $10.54 | $10.125 | $10.32 | 1.59M |
| Sep 29, 2026 | $10.03 | $10.415 | $10.00 | $10.37 | 1.73M |
| Sep 28, 2026 | $10.00 | $10.06 | $9.80 | $10.05 | 1.71M |
| Sep 25, 2026 | $9.80 | $10.32 | $9.7238 | $10.12 | 3M |
| Sep 24, 2026 | $10.028 | $10.05 | $9.83 | $9.92 | 1.66M |
| Sep 23, 2026 | $10.22 | $10.275 | $9.94 | $10.03 | 1.63M |
| Sep 22, 2026 | $10.45 | $10.50 | $10.27 | $10.33 | 1.21M |
| Sep 21, 2026 | $10.27 | $10.32 | $10.06 | $10.17 | 1.7M |
| Sep 18, 2026 | $10.24 | $10.54 | $10.17 | $10.18 | 2.79M |
| Sep 17, 2026 | $10.45 | $10.53 | $10.02 | $10.28 | 2.76M |
| Sep 16, 2026 | $10.63 | $10.76 | $10.43 | $10.50 | 2.73M |
| Sep 15, 2026 | $10.80 | $10.94 | $10.61 | $10.66 | 2.87M |
| Sep 14, 2026 | $10.49 | $11.03 | $10.3901 | $10.86 | 4.18M |
| Sep 11, 2026 | $9.55 | $10.60 | $9.34 | $10.58 | 6.46M |
| Sep 10, 2026 | $8.77 | $8.92 | $8.60 | $8.84 | 2.38M |
| Sep 9, 2026 | $9.23 | $9.435 | $8.842 | $8.985 | 3.05M |
| Sep 8, 2026 | $9.55 | $9.55 | $9.035 | $9.19 | 1.76M |
The latest Smart Investors Daily articles mentioning ATEC.
Company
Market Activity
Research & News
ATEC research
Company profile and research snapshot.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 5, 2026 | UBS | Buy | — |
| Aug 5, 2026 | TD Cowen | Buy | — |
| Aug 5, 2026 | BMO Capital | Outperform | — |
| Jul 28, 2026 | UBS | Buy | — |
| Jul 23, 2026 | Stephens & Co. | Overweight | — |
No generated briefing is available yet.
Yahoo · Jan 30, 2026
Alphatec Holdings Inc. (NASDAQ:ATEC) is one of the best high short interest stocks with biggest upside potential. On January 27, TD Cowen lowered its price target for Alphatec to $20 from $27 while maintaining a Buy rating following a transfer of coverage. The firm suggested that the current market expectations do not fully appreciate the […]
SeekingAlpha · Jan 25, 2026
SeekingAlpha · Jan 14, 2026
Alphatec Holdings, Inc. (ATEC) 44th Annual J.P.
SeekingAlpha · Jan 13, 2026
Alphatec Holdings, Inc. is rated Hold, continues to deliver strong top-line growth and operational leverage. Learn more about ATEC stock here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ATEC.
